









Markets
/
Stocks
/
nasdaq-actu
/

Actuate Therapeutics Inc

ACTU

7.070USD

-0.190-2.62%

Close 08/04, 16:00（ET）Quotes delayed by 15 min

138.09MMarket Cap

LossP/E TTM



Actuate Therapeutics Inc

7.070

-0.190-2.62%

Overview Company Financials

Income Statement

Cash Flow Statement

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q1

Operating expenses

-18.11%6.37M

--6.56M

--5.39M

--5.44M

46.71%7.77M

--5.30M

R&D expenses

-53.06%3.22M

--3.69M

--3.76M

--4.37M

51.65%6.86M

--4.52M

Operating profit

18.11%-6.37M

---6.56M

---5.39M

---5.44M

-46.71%-7.77M

---5.30M

Net non-operating interest income (expenses)

Non-operating interest income

262.66%53.62K

--118.11K

--80.75K

--8.64K

-71.37%14.79K

--51.65K

Non-operating interest expense

-0.26%5.06K

--5.08K

--3.49K

--5.08K

-82.16%5.08K

--28.45K

Special income (expenses)

100.00%0.00

--0.00

---655.32K

---1.14M

-10533.29%-532.51K

--5.10K

Income before tax

23.86%-6.32M

---6.45M

---5.97M

---6.57M

-57.41%-8.30M

---5.27M

Income after tax

23.86%-6.32M

---6.45M

---5.97M

---6.57M

-57.41%-8.30M

---5.27M

Net income from continuous operations

23.86%-6.32M

---6.45M

---5.97M

---6.57M

-57.41%-8.30M

---5.27M

Net income attributable to controlling interests

23.86%-6.32M

---6.45M

---5.97M

---6.57M

-57.41%-8.30M

---5.27M

Net income attributable to common shareholders

23.86%-6.32M

---6.45M

---5.97M

---6.57M

-57.41%-8.30M

---5.27M

Basic earnings per share

25.36%-0.32

---0.31

---0.31

---0.34

-57.41%-0.43

---0.28

Diluted earnings per share

25.36%-0.32

---0.31

---0.31

---0.34

-57.41%-0.43

---0.28

Dividend per share

--0.00

--0.00

--0.00

--0.00

--0.00

--0.00

Currency unit

USD

USD

USD

USD

USD

USD

Audit opinions

--

--

--

--

--

--

KeyAI

